Incyte (INCY) 10-Q2024 Q1 Quarterly report

Filed: 30 Apr 24, 4:02pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: AA, aesthetic, allocated, amenable, amplification, antagonist, artificial, ASU, Barry, binder, blocking, burdensome, catastrophe, cholestatic, CIndU, CMSHL, conference, Cooperation, CSU, customary, deficient, degranulation, disaster, domain, East, electronic, eradicate, Escient, feedback, FL, Flannelly, gave, imposition, inaccurate, insolvency, intelligence, mast, merge, merger, mid, Middle, MPN, MZL, newly, nodule, North, ovarian, Overexpression, physical, Pillar, problem, promptly, pseudokinase, radiation, ransomware, registration, revert, roll, Skinhealth, software, sparing, staying, sublicense, substance, substantive, successor, surgery, territory, thereof, topline, uncured, uremic, waived, waiver, WT, Yverdon

Removed: accredited, acknowledged, adding, alliance, Biopharma, booking, capecitabine, collect, colorectal, commenced, competitively, curtailment, curve, deficit, demonstrate, direction, discontinued, EC, efficiently, eleven, employer, eventual, exist, Fc, fear, finite, funded, gaining, hesitancy, home, Ib, IIa, IIb, impairment, imposed, initiative, InnoCare, inspection, intrusion, IRA, Kingdom, launch, Leadership, LIMBER, Maruho, narrower, offer, pancreatic, perception, Pharma, prioritize, quarantine, recommend, recoverability, recruiting, regorafenib, remote, restriction, retaining, rollforward, School, shutdown, Sprl, suboptimal, succeeded, threshold, UCB, visitor, warrant, worked

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated INCY transcripts

INCY similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

STATEMENT PURSUANT TO

18 U.S.C. SECTION 1350

With reference to the Quarterly Report of Incyte Corporation (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Hervé Hoppenot, Chief Executive Officer of the Company, certify, for the purposes of 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


			/s/ HERVÉ HOPPENOT

			Hervé Hoppenot
			Chief Executive Officer
			April 30, 2024